
MedBioInformatics Solutions
@medbiosolutions
Unlocking the potential of genomics for healthcare and drug R&D.
We provide the DISGENET plus knowledge platform.
disgenetplus.com
ID: 1422577698325598214
https://www.medbioinformatics.com/ 03-08-2021 15:19:46
40 Tweet
46 Followers
8 Following


Finally, the flash talks ⚡ session moderated by Montse Daban from Biocat. 💬 We have different organisations sharing their works and experiences! Genomcore Made of Genes @permedcoe BSC-CNS Butler Scientifics @IMOMA_Asturias MedBioInformatics Solutions


👉🏽 Check our new post on genetic support for FDA drug approvals in 2021 🧬DISGENET plus has genetic support for 90% of FDA drug approvals in 2021 📚This surpasses publicly available resources, which support 66% of drug approvals #drugefficacy #Genetics medbioinformatics.com/genetic-suppor…

Congrats to Jordi Valls-Margarit for best poster award with his work on #insilico tools for #chemical #riskassessment 🧪🧬💊RISK-HUNT3R





Fresh from the oven - check out the latest publication from eTRANSAFE! doi.org/10.1016/j.csbj… Innovative Health Initiative #H2020 #toxicology #drugsafety #insilico

We are proud to have been part of eTRANSAFE Project to empower translational #safetyassessment with #DataScience #textmining #AI #networkscience nature.com/articles/d4157…



🙌🏽 Academically coordinated by the UPF Barcelona's Prof. Ferran Sanz, coordinator of the Biomedical Informatics Research Unit at GRIB, the project involved researchers from Bioinformatics GRIB and MedBioInformatics Solutions



🔗Curious to learn more? Check out the published results in Nature Reviews Drug Discovery: nature.com/articles/d4157… #ScienceResearch #DrugSafety eTRANSAFE Project



🗣️New article from our team! Benchmarking of #network #biology approaches for systems #toxicology This work is part of our efforts to develop #insilico novel approaches for #chemical #riskassessment in the context of RISK-HUNT3R doi.org/10.3389/fphar.…


IMI project result: our eTRANSAFE Project project developed an 'app' to make it easier for researchers to analyse which #biomarkers are being used in which #clinical studies. Find out more: europa.eu/!qBdGXG
